UCSF seeks answer for most severe form of ‘bubble baby’ disease


UCSF, a consortium of centers treating immunodeficiency diseases, California's stem cell research funding agency, the NIH and the FDA are responsible for a 10-patient clinical trial with life-changing results.

Previous Genentech's Actemra approved for hospitalized Covid-19 patients
Next Retail concept emerged in Downtown Albuquerque out of Covid constraints